HD-OPM Archive

Protecting your brain: heart health and dementia prevention

How the health of your arteries and your brain are tied together, which risk factors the 2024 Lancet Commission highlights, and what the group's posts say about diet, lipids, blood pressure, vaccines, supplements and drugs in dementia prevention.

18 min read59 group posts cited55 studies discussed4 chartsEvidence through Oct 2026AI Summary of posts by Louis Nervegna and Gokhan Can
Key takeaways
  • The 2024 Lancet Commission estimated that 14 modifiable risk factors account for about 45% of dementia cases, with high LDL cholesterol and untreated hearing loss each responsible for about 7%.
  • Atherosclerosis, high blood pressure and high LDL/apoB are consistently linked to higher dementia risk, so keeping apoB and blood pressure optimal is framed as protecting heart and brain together.
  • The MIND diet is described as the best-supported nutritional approach; in one Rush analysis high adherence was associated with a 53% lower Alzheimer's risk and moderate adherence with about a third lower risk (observational).
  • Statins are not linked to brain harm: observational meta-analyses show 14-20% lower dementia risk among users, and two large randomized trials (PREVENTABLE, 20,000 people over 75, and STAREE, 10,000 people over 70) should settle whether the benefit is real.
  • Processed meat is associated with higher dementia risk (13% per daily serving in one study), while 2 g/day of DHA from fish oil did not slow cognitive decline in the 365-person PREVENT-E4 trial.
  • Many exciting findings (ezetimibe, lithium, metformin, shingles and flu vaccines, obicetrapib) are observational, biomarker-only or early-stage and still need randomized confirmation.
In this summary
  1. How the heart, the vessels and the brain are connected
  2. Cholesterol and the brain: clearing up the confusion
  3. Diet and lifestyle: what the evidence shows
  4. Nuances, controversies and open questions
  5. Blood pressure, drugs and vaccines
  6. Supplements and unproven ideas
  7. Testing and early detection
  8. What this means for you
  9. Frequently asked questions
  10. The evidence behind this summary

Dementia and heart disease are far more closely related than most people assume. The same processes that clog and stiffen arteries in the heart also damage the small vessels that feed the brain, and the risk factors overlap heavily. Louis Nervegna, one of the group's admins, puts it bluntly: heart health and brain health are "inextricably linked", and everything done to look after the heart and arteries also helps the brain.1 That is why dementia comes up so often in this group.

The headline number comes from the 2024 Lancet Commission on dementia prevention, intervention and care. It identified 14 modifiable risk factors that together account for about 45% of dementia cases.23 Two newly added factors were high LDL cholesterol and vision loss. Midlife high LDL and untreated midlife hearing loss are each credited with roughly 7% of cases, making them the two largest single factors.24 Walter Willett of Harvard, quoted in a post, thinks the true preventable share may be even higher, and says diet cannot eliminate dementia but can "put it off for some years".5

This article walks through what the group's posts say about how vascular health and dementia connect, what lifestyle and dietary patterns are linked to lower risk, what is known (and not yet known) about cholesterol drugs and the brain, and which of the more speculative ideas have evidence behind them. Most of the evidence discussed is observational, meaning it shows associations rather than proof of cause, and the article flags this where the posts do.

45%of dementia cases are linked to 14 modifiable risk factors (2024 Lancet Commission)2
7%of cases each from midlife high LDL and untreated hearing loss, the two largest single factors4
53%lower Alzheimer's risk with high MIND diet adherence in Rush cohort studies6
20%lower dementia risk with statin use in a meta-analysis of 36 observational studies7

How the heart, the vessels and the brain are connected

A shared post titled "Brains and blood vessels" explains the link. Atherosclerosis (plaque build-up in arteries), endothelial dysfunction (poor function of the lining of blood vessels), high blood pressure and high LDL/apoB are consistently associated with higher risk of dementia, including Alzheimer's. Poor vessel health can reduce blood flow to the brain, disturb the blood-brain barrier (the filter between blood and brain tissue) and promote chronic inflammation and oxidative stress. Genetic analyses also show overlap between Alzheimer's risk, genetic tendencies towards higher blood lipids and coronary artery disease. The post's conclusion is that keeping apoB and blood pressure optimal, and improving endothelial function, insulin sensitivity and inflammation, protects heart and brain together.8

Brain arteries from the "Brains and blood vessels" post: panel A shows vessels from healthy older adults, panel B from older adults with Alzheimer's, whose vessels look thicker-walled and narrower.
Brain arteries from the "Brains and blood vessels" post: panel A shows vessels from healthy older adults, panel B from older adults with Alzheimer's, whose vessels look thicker-walled and narrower.8

Heart function itself appears to matter. A Vanderbilt study of 756 adults aged 50 to 92, followed for up to 11 years, found that in carriers of the APOE4 gene variant (the strongest common genetic risk factor for late-onset Alzheimer's), lower cardiac output (how much blood the heart pumps per minute) was associated with smaller brain volumes at baseline and faster shrinkage of the temporal lobe over time. This was in people without diagnosed cardiovascular disease.1

Hearing, vision and other factors

Beyond cholesterol, the posts highlight hearing loss. Louis states that untreated midlife hearing loss is responsible for about 7% of dementia cases, tied with LDL as the largest modifiable factor, and advises that hearing loss be treated promptly to protect the brain.49 The Commission also added vision loss in later life as a modifiable risk.24

The 2024 Lancet Commission's 14 modifiable dementia risk factors across early life, midlife and late life, with the share of cases each accounts for; midlife hearing loss and high LDL cholesterol are the largest, and together the factors add up to 45% of cases.
The 2024 Lancet Commission's 14 modifiable dementia risk factors across early life, midlife and late life, with the share of cases each accounts for; midlife hearing loss and high LDL cholesterol are the largest, and together the factors add up to 45% of cases.4

Cholesterol and the brain: clearing up the confusion

A frequent claim in online circles is that high blood cholesterol protects the brain or that lowering LDL harms it. Louis disputes this on physiological grounds. The brain makes essentially all of its own cholesterol locally, and cholesterol circulating in the blood cannot cross the blood-brain barrier.31314 On that basis he argues that PCSK9 inhibitors, ezetimibe and bempedoic acid, which only lower cholesterol in the blood, have no effect on brain cholesterol production.1314 Hydrophilic (water-soluble) statins such as rosuvastatin cross the barrier poorly, whereas lipophilic (fat-soluble) statins such as atorvastatin do enter the brain.14

His reading of the Lancet Commission is that high LDL is "the opposite" of protective: it is listed as the largest modifiable dementia risk factor, responsible for about 7% of cases.23

Do statins protect the brain?

Several posts cover the statin question, and the picture is encouraging but not final.

  • Observational meta-analyses. A meta-analysis of observational studies reported statin use associated with 20% lower dementia risk (36 studies, odds ratio 0.80) and 32% lower Alzheimer's risk (21 studies, odds ratio 0.68). The authors concluded this confirms the absence of a neurocognitive risk from statins and suggests a possible benefit, but called for dedicated randomized trials.7

A later review of 55 studies covering about 7 million people found 14% lower all-cause dementia and 18% lower Alzheimer's risk; Louis points out these were cohort and case-control studies, not randomized trials.15

  • Existing dementia. A Swedish registry cohort of 15,586 people with Alzheimer's or mixed dementia found statin users declined more slowly, scoring on average 0.63 points higher on the MMSE (a standard memory and thinking test) after three years. The lead author cautioned this is not evidence that people with dementia should be started on statins, but that a dementia diagnosis should not stop statin treatment in someone who needs it for blood lipids.16 Louis also notes that two earlier trials found lipophilic statins did not worsen existing Alzheimer's, though they did not clearly help either.14
  • Randomized trials in progress. PREVENTABLE is randomizing about 20,000 community-dwelling adults aged 75 or older, free of cardiovascular disease and dementia, to atorvastatin 40 mg or placebo; it began in 2020, runs up to 5 years and has a primary outcome of new dementia diagnosis. Atorvastatin was chosen because it is lipophilic.12 STAREE, about 10,000 adults aged 70+ taking atorvastatin 40 mg or placebo, is complete with a primary outcome of disability-free survival (which includes freedom from dementia). Louis reasons that because it was not stopped early for harm or for overwhelming benefit, the result probably lies in between, which is an inference rather than a result.17
Statin users had less dementia, not moreOdds of dementia and Alzheimer's disease in statin users versus non-users, meta-analysis of observational studies
interval clear of 195% confidence interval
All dementia (36 studies)0.80 (0.75–0.86)
Alzheimer's disease (21 studies)0.68 (0.56–0.81)
Observational studies; randomized trials (PREVENTABLE, STAREE) are needed to show whether statins protect the brain. Source: 7
Show data
Odds ratio (log scale)95% CI
All dementia (36 studies)0.800.75–0.86
Alzheimer's disease (21 studies)0.680.56–0.81

Ezetimibe, obicetrapib and the APOE4 question

Several posts cover other lipid drugs. A 2024 Aging Biology analysis of clinical databases (nearly 950,000 older adults) found that ezetimibe users had markedly lower rates of Alzheimer's and related dementias, reported as an 86% lower risk, and over 88% lower in high-risk people with heart disease.1819 Lab work in the same paper showed ezetimibe reducing protein aggregation in cultured neurons.19 The posts stress this is an observational association with preliminary findings that need confirmation.1819 This sits somewhat awkwardly alongside the argument that ezetimibe does not act on brain cholesterol, a tension the posts do not resolve.

Obicetrapib, a CETP inhibitor that lowers LDL and raises HDL, is a newer story. In the phase 3 BROADWAY trial it lowered LDL by 29.9% over one year, and a biomarker substudy of 1,535 participants (367 APOE4 carriers) found lower p-tau217, a blood marker of Alzheimer's pathology, with the largest effect in carriers of two APOE4 copies (20.5% lower than placebo).20 Another post reports all five biomarkers moving in the right direction (p-tau217, Abeta42/40, their ratio, GFAP and NfL), with placebo-adjusted benefits of 13.67 to 22.65%.21 The caveats are explicit: these are biomarkers, not cognitive outcomes, from a post hoc subgroup that needs replication.2021 A Mendelian randomization analysis (a genetic method that approximates a natural randomized experiment) found the CETP benefit strongest in APOE4 carriers, but Louis describes this as early and not proof of clinical benefit.22

DrugReaches brain cholesterol?What the posts report on dementia
Atorvastatin (lipophilic statin)Enters the brainStatins linked to lower dementia risk in observational studies; tested at 40 mg in PREVENTABLE and STAREE7121417
Rosuvastatin (hydrophilic statin)Crosses the barrier poorlyNot discussed separately14
PCSK9 inhibitors, bempedoic acidNo effect on brain cholesterol, per LouisNo dementia data in the posts1314
EzetimibeNo effect on brain cholesterol, per Louis86% lower Alzheimer's and related dementia risk in a database analysis; observational1819
Obicetrapib (CETP inhibitor)Not discussedLower p-tau217 and other blood biomarkers in a BROADWAY substudy; no cognitive outcomes yet2021

Mechanistic work from Mount Sinai suggests why APOE4 may make cholesterol handling in the brain matter. In human stem-cell-derived "miBrain" tissue, APOE4 caused cholesterol to accumulate in astrocytes (support cells), impairing waste disposal and promoting toxic protein deposits. A second study found APOE4 also damages brain blood vessels through mechanisms unrelated to cholesterol. This is laboratory evidence, not a clinical result.23

Diet and lifestyle: what the evidence shows

The MIND diet

Louis describes the MIND diet (Mediterranean-DASH Intervention for Neurodegenerative Delay) as the best evidence-based nutritional approach for preventing dementia and says most neurologists now recommend it, with benefit regardless of APOE4 status.11 It combines the Mediterranean and DASH diets, emphasizing vegetables (especially leafy greens), berries, nuts, legumes, whole grains, olive oil, fish and poultry while limiting red meat, fried foods, butter, full-fat cheese, pastries and sweets.6 Willett highlights carotenoid-rich vegetables, berries and a modest amount of omega-3 from oily fish and nuts.5

Reported associations from Rush University: high adherence was linked to a 53% lower Alzheimer's risk, moderate adherence to about a third lower risk, and high adherence to cognition equivalent to someone 7.5 years younger.6 A related autopsy study of 809 people found MIND adherence associated with less hippocampal sclerosis in brain tissue.6 These are cohort studies, not randomized trials.

Among Mediterranean diet findings, Harvard cohort data (Nurses' Health Study and Health Professionals Follow-up Study) found higher Mediterranean adherence associated with lower dementia risk overall and about a 35% lower risk per one-unit score increase among people with two APOE4 copies, consistent with the PREDIMED trial but observational.24

A healthy lifestyle even when pathology is present

An observational study of 586 people examined at autopsy, with up to 24 years of lifestyle data, found that a healthy lifestyle (not smoking, at least 150 minutes a week of moderate to vigorous exercise, about one drink a day for women or two for men, regular mental stimulation and the MIND diet) was associated with less cognitive decline even in brains showing amyloid or tau. Louis notes that light to moderate alcohol was associated with protection in this study, and that the same lifestyle that protects the heart protects the brain.10

Eggs, nuts, beans and processed meat

Louis shared several cohort studies linking eggs to lower Alzheimer's risk. A Rush Memory and Aging Project analysis of 1,024 people (average age about 81, followed 6.7 years) found more than one egg per week associated with 47% lower Alzheimer's dementia risk, with dietary choline explaining about 39% of the association.2526 Louis adds that the choline in eggs (phosphatidylcholine) does not raise TMAO.2526 But a later Adventist Health Study analysis (about 40,000 people over 15 years) found nuts and beans protective to a similar degree, around 12 almonds or a third of a cup of lentils matching the egg effect, which weakens a choline-only explanation. Louis's takeaway is to swap eggs in for red and processed meat rather than for nuts or beans.27 A proposed mechanism is that choline, via phosphatidylcholine, protects mitochondrial membranes; Louis notes the older acetylcholine explanation never made much sense because dietary choline barely raises brain acetylcholine.28

On the other side, processed meat is consistently unfavorable:

  • A large study linked one daily serving of processed red meat to 13% higher dementia risk and 1.6 years of accelerated cognitive aging, while replacing it with nuts, legumes or fish was associated with 20% lower risk.29
  • A review in the Annual Review of Nutrition reported about two slices of deli meat daily linked to 44% higher dementia risk and 52% higher Alzheimer's risk, and replacing 10% of ultra-processed food calories with unprocessed food linked to 19% lower dementia risk.30
Processed meat up, healthier swaps downChange in dementia or Alzheimer's risk in the studies cited above
Deli meat, about two slices a day: Alzheimer's+52%
Deli meat, about two slices a day: dementia+44%
Processed red meat, one serving a day: dementia+13%
Replacing 10% of ultra-processed calories with unprocessed food: dementia−19%
Replacing processed red meat with nuts, legumes or fish: dementia−20%
Observational studies with different designs and populations; compare direction, not exact size. Source: 2930
Show data
Value
Deli meat, about two slices a day: Alzheimer's+52%
Deli meat, about two slices a day: dementia+44%
Processed red meat, one serving a day: dementia+13%
Replacing 10% of ultra-processed calories with unprocessed food: dementia−19%
Replacing processed red meat with nuts, legumes or fish: dementia−20%

Strong legs and muscle

Louis called a 10-year study of 324 female twins "fascinating" because the twin design makes confounding and reverse causality less likely: greater leg power at baseline predicted slower cognitive decline and better-preserved grey matter.31

Nuances, controversies and open questions

Meat, fish and APOE4

A widely shared Swedish observational study found that carriers of APOE 3/4 or 4/4 who ate unprocessed meat or fish had lower dementia risk, with fish, poultry and red meat showing similar benefit and no benefit in non-carriers; processed meat was associated with higher risk in everyone.11 Louis stresses that intakes were modest (mean total meat 77 g/day) and that most people eating a Mediterranean or MIND-style diet probably already reach the top-fifth intake of about 2.5 oz per day of fish or poultry, if the results are even causal.1132 Hussein Yassine's commentary adds a caution: with 569 APOE 3/4 and 4/4 participants and 296 dementia cases, the study was underpowered for the dementia interaction (P = 0.10), while the cognitive trajectory interaction was significant (P = 0.004). He calls for genotype-randomized nutrition trials.33

Omega-3 and DHA

In the randomized PREVENT-E4 trial, 365 adults aged 55 to 80 who rarely ate fish (47% APOE4 carriers) took 2,000 mg DHA daily for two years. There was no difference in cognition or hippocampal volume versus placebo, though DHA reached spinal fluid equally in carriers and non-carriers. Louis notes the trial was small, primarily designed to test brain delivery, and its cognitive findings are exploratory; APOE4 carriers with the largest rise in the DHA-to-arachidonic-acid ratio did show less decline.3435 A Rutgers trial is testing plant omega-3 ALA in APOE4 carriers with mild cognitive impairment, based on the hypothesis that APOE4 impairs DHA transport into the brain.36 A post on a 2025 lipidomics study of 841 adults reported lower omega-3-rich lipids in women with Alzheimer's but not men, and cited a review of 58 randomized trials suggesting 1,000-2,500 mg/day of EPA plus DHA as the best range for cognition.37 Note the apparent tension with PREVENT-E4's null result at 2 g DHA in cognitively unimpaired older adults.

Alzheimer's is often a mixed disease

A study of autopsy data reported that "pure" Alzheimer's is rare and most dementia involves multiple pathologies, especially in APOE4 carriers, which may help explain limited benefit from anti-amyloid drugs in people with two APOE4 copies.38 Anti-amyloid antibodies (lecanemab and donanemab) slow decline by roughly 30% in early disease, but benefits are modest and limited by amyloid-related imaging abnormalities.39 Lewy body dementia, the second most common dementia, is marked by alpha-synuclein clumping and is on a spectrum with Parkinson's.40

Desmosterol testing

Louis calls the Boston Heart desmosterol blood test likely a waste of money. He argues that in healthy people higher, not lower, desmosterol is associated with dementia risk, and that statin response can be judged simply by trying a statin.41

Blood pressure, drugs and vaccines

  • Blood pressure. A Chinese study shared by Dale Bredesen linked keeping blood pressure below 130/80 with 15% lower dementia risk and 16% lower overall cognitive impairment.42 An autopsy cohort found drugs that stimulate angiotensin II signaling (ARBs, thiazides, dihydropyridine calcium channel blockers) associated with 14-21% lower Alzheimer's biomarker levels, and 24% lower arteriolosclerosis with 15+ years of use, compared with those that inhibit it (ACE inhibitors, beta blockers, non-dihydropyridine calcium channel blockers).43
  • Metformin. A 20+ year follow-up of the Diabetes Prevention Program found participants originally randomized to metformin had 60-62% lower odds of adjudicated dementia, but the post notes the follow-up became open-label, so it is an observational analysis of a randomized trial and not conclusive.44
  • Vaccines. Louis cites accumulating evidence that the shingles vaccine protects against dementia, with randomized trials expected, and a high-dose flu vaccine study (nearly 200,000 people over 65) associated with about 55% lower Alzheimer's risk, versus 40% for standard dose. He repeatedly cautions that healthier people may simply be more likely to get vaccinated.4546
High-dose flu shots tracked with less Alzheimer's than standard dosesLower Alzheimer's risk with flu vaccination, nearly 200,000 people aged 65 and older (Neurology)
High-dose flu vaccinenearly −55%
Standard-dose flu vaccine−40%
Observational; people who get vaccinated may take better care of their health in general. Source: 46
Show data
Value
High-dose flu vaccinenearly −55%
Standard-dose flu vaccine−40%

Supplements and unproven ideas

  • B vitamins. In the Oxford VITACOG trial in people with mild cognitive impairment, folate, B6 and B12 cut brain shrinkage by an average of 30% over two years, up to 53% in those with high homocysteine; later analyses suggested benefit depended on high omega-3 blood levels.47 A Tufts article highlights benefit in older people with high homocysteine.48 In a UCSF study of 231 healthy older adults, lower active B12 was linked to slower processing speed and more white matter lesions even when total B12 was above the deficiency cutoff; Louis wonders if B12 explains the cognitive benefit of a multivitamin in the COSMOS trial.49
  • Vitamin C. Low blood vitamin C was linked to less grey matter in over 2,000 older Japanese adults; Louis thinks it is a proxy for fruit and vegetable intake.50
  • Creatine. A summary reports 20 g/day for 8 weeks improved cognition in Alzheimer's patients by nearly 5%.51
  • Combined metabolic activators. A 69-person phase II trial of L-serine, nicotinamide riboside, N-acetylcysteine and L-carnitine tartrate reported 29% cognitive improvement versus 14% on placebo over almost three months, which Louis called the most impressive Alzheimer's supplement trial he had seen; a larger phase 3 is planned.52
  • Lithium. A Harvard study in Nature found lithium loss in the brain is an early change in Alzheimer's and lithium orotate restored memory in mice; human trials at MGH/Brigham were expected in spring 2026. This is early evidence.5354 Louis corrected a shared post: low-dose lithium inhibits overactive mTOR in the brain.55
  • Fecal transplant. A single case report of an 82-year-old man whose cognition improved after fecal microbiota transplant; one case cannot show effectiveness.56
A small trial of four metabolic activators in Alzheimer'sCognitive improvement over almost three months, phase II trial of L-serine, nicotinamide riboside, N-acetylcysteine and L-carnitine tartrate (69 patients)
Metabolic activators29%
Placebo14%
Small phase II trial (47 on treatment, 22 on placebo); a larger phase 3 is planned. Source: 52
Show data
Value
Metabolic activators29%
Placebo14%

Testing and early detection

Blood tests for p-tau217 are becoming practical. A study of 2,766 women followed up to 25 years found each standard deviation rise tripled dementia risk and the top quartile had 7 times the risk of the bottom.57 A finger-prick version could one day make screening cheaper and help people track which interventions work.58 Framingham data linked lower small dense LDL and higher fat-transport markers to lower Alzheimer's risk.59

What this means for you

  • Keep apoB/LDL and blood pressure under good control; the group's framing is that arterial health protects the brain.2842
  • The group's admins suggest discussing hearing and vision checks with your doctor, as untreated hearing loss is credited with about 7% of dementia cases.49
  • Louis recommends a MIND or Mediterranean-style pattern, with plenty of vegetables, berries, nuts, beans and fish, and avoiding processed meat.61129
  • Regular exercise (150+ minutes a week) and leg strength are linked to better cognitive aging.1031
  • If a statin is otherwise indicated, current evidence shows no sign of brain harm; the group is awaiting PREVENTABLE and STAREE for the definitive answer.7121617
  • Treat headline-grabbing supplement and drug findings as hypotheses until randomized trials confirm them.182144

Frequently asked questions

Does lowering LDL cholesterol harm the brain?

Louis argues it does not: blood cholesterol cannot cross the blood-brain barrier, the brain makes its own, and the Lancet Commission lists high LDL as a dementia risk factor rather than a protective one.313 Observational meta-analyses of statins found lower, not higher, dementia risk.715

Can lifestyle help if early Alzheimer's changes are already present?

An observational autopsy cohort suggests so: a healthy lifestyle was associated with less cognitive decline even with amyloid or tau present.10 The Rush data likewise link MIND adherence to less hippocampal damage.6

Should APOE4 carriers eat more meat?

Not on this evidence. The Swedish study is observational and underpowered for dementia, benefits were similar for fish and poultry, and processed meat was harmful regardless of genotype.113233

Is fish oil worth taking for the brain?

A 2 g/day DHA trial for two years found no cognitive benefit in at-risk older adults, though it was small and short.3435 Longer or differently designed trials, including one of plant ALA, are under way.36

Are vaccines protective against dementia?

Observational studies suggest shingles and high-dose flu vaccines are associated with lower dementia risk, but confounding by healthier behavior is possible.4546

The evidence behind this summary55 studies · 2 meta-analyses · 9 trials · 1 MR · 22 observational

The 59 group posts cited above discuss 55 studies and sources. Their mix of study designs shows how much rests on randomized trials and meta-analyses, which can show cause and effect, and how much on observational, lab or animal work, which mostly cannot.

Meta-analyses 2Randomized trials 9Mendelian randomization 1Observational studies 22Reviews & guidelines 9Animal & lab studies 3Other sources 9

Strongest evidence discussed

All 55 studies and sources
Sources from the group (59)
  1. Lower cardiac output predicts faster brain shrinkage in APOE4 carriers Louis Nervegna · Aug 08, 2026 · Facebook
  2. 2024 Lancet Commission: high LDL is the top modifiable dementia risk factor (7% of cases) Louis Nervegna · Aug 08, 2024 · Facebook
  3. High LDL does not protect the brain: 2024 Lancet Commission lists LDL as top dementia risk Louis Nervegna · Dec 15, 2024 · Facebook
  4. Lancet Commission 2024: high LDL and hearing loss each account for 7% of dementia cases Louis Nervegna · Jun 16, 2025 · Facebook
  5. Nearly half of dementia cases may be preventable; Willett recommends the MIND diet Louis Nervegna · Aug 26, 2026 · Facebook
  6. MIND diet adherence linked to 53% lower Alzheimer's risk and brain 7.5 years younger Louis Nervegna · Aug 11, 2025 · Facebook
  7. Statin use linked to 20% lower dementia and 32% lower Alzheimer's risk in meta-analysis Louis Nervegna · Oct 22, 2024 · Facebook
  8. Atherosclerosis drivers such as high apoB and blood pressure also raise dementia risk Louis Nervegna · Jun 05, 2026 · Facebook
  9. Untreated midlife hearing loss causes about 7% of dementia cases (2024 Lancet Commission) Louis Nervegna · Oct 23, 2025 · Facebook
  10. Healthy lifestyle tied to less dementia despite amyloid and tau in the brain (n=586) Louis Nervegna · Feb 06, 2024 · Facebook
  11. APOE4 carriers eating unprocessed meat or fish had lower dementia risk in Swedish study Louis Nervegna · Mar 23, 2026 · Facebook
  12. PREVENTABLE: 20,000-person trial of atorvastatin 40 mg to prevent dementia over age 75 Louis Nervegna · Jun 23, 2025 · Facebook
  13. PCSK9 inhibitors lower circulating cholesterol only, not brain cholesterol Louis Nervegna · Mar 09, 2025 · Facebook
  14. Only lipophilic statins like atorvastatin enter the brain; PCSK9 drugs and ezetimibe don't Louis Nervegna · Oct 18, 2025 · Facebook
  15. Statin users had 14% lower dementia risk in a meta-analysis of 7 million people Louis Nervegna · Aug 05, 2026 · Facebook
  16. Statin use linked to slower cognitive decline in Alzheimer's and mixed dementia Louis Nervegna · Dec 25, 2025 · Facebook
  17. STAREE statin trial in 10,000 people over 70 is complete; no major harm or big benefit Louis Nervegna · May 26, 2026 · Facebook
  18. Ezetimibe use linked to 86% lower Alzheimer's and dementia risk in database analysis Louis Nervegna · Oct 19, 2026 · Facebook
  19. Ezetimibe linked to lower Alzheimer's risk in database analysis and lab experiments Gokhan Can · Aug 07, 2024 · Facebook
  20. Obicetrapib lowered Alzheimer's marker p-tau217, most in APOE4 carriers (BROADWAY) Louis Nervegna · Jul 24, 2026 · Facebook
  21. Obicetrapib improved Alzheimer's biomarkers, most in APOE4/4 carriers (BROADWAY substudy) Louis Nervegna · May 23, 2026 · Facebook
  22. CETP inhibitors might help prevent Alzheimer's and Lewy body dementia in APOE4 carriers Louis Nervegna · May 24, 2026 · Facebook
  23. APOE4 drives cholesterol buildup in brain astrocytes, promoting toxic protein deposits Louis Nervegna · Oct 06, 2026 · Facebook
  24. Mediterranean diet linked to 35% lower Alzheimer's risk in ApoE4/4 carriers Louis Nervegna · Aug 27, 2025 · Facebook
  25. Rush study: more than 1 egg per week linked to 47% lower Alzheimer's dementia risk Louis Nervegna · Mar 13, 2025 · Facebook
  26. Eating eggs weekly linked to lower Alzheimer's dementia risk in older adults Louis Nervegna · Jul 14, 2025 · Facebook
  27. Adventist Health Study: nuts and beans protected against dementia as much as eggs Louis Nervegna · May 27, 2026 · Facebook
  28. Dietary choline may protect mitochondria and slow brain-cell aging, a dementia mechanism Louis Nervegna · Aug 22, 2026 · Facebook
  29. Daily processed red meat linked to 13% higher dementia risk; swaps lower it 20% Louis Nervegna · Jan 31, 2025 · Facebook
  30. Two slices of deli meat a day linked to 44% higher dementia risk in a new review Louis Nervegna · Oct 02, 2026 · Facebook
  31. Leg power predicted cognitive ageing over ten years in older female twins Louis Nervegna · Aug 24, 2025 · Facebook
  32. Most omnivores already eat enough fish or poultry for the APOE4 benefit in a Swedish study Louis Nervegna · Mar 24, 2026 · Facebook
  33. Yassine: Swedish APOE4 meat study underpowered for dementia but significant for cognition Louis Nervegna · Mar 24, 2026 · Facebook
  34. PREVENT-E4: 2 g/day DHA did not slow cognitive decline in 365 at-risk older adults Louis Nervegna · Jun 19, 2026 · Facebook
  35. High-dose DHA did not slow cognitive decline in 2-year APOE4 trial, but reached the brain Louis Nervegna · Jun 27, 2026 · Facebook
  36. Rutgers trial tests plant omega-3 ALA for early Alzheimer's in APOE4 carriers Louis Nervegna · May 14, 2026 · Facebook
  37. Women with Alzheimer's show lower omega-3 lipids, unlike men, in an 841-adult study Louis Nervegna · Dec 17, 2025 · Facebook
  38. Pure Alzheimer's is rare; most cases have mixed brain pathology at autopsy Louis Nervegna · Nov 20, 2025 · Facebook
  39. Anti-amyloid antibodies slow early Alzheimer's decline ~30%, with modest benefit and risks Louis Nervegna · Jun 22, 2026 · Facebook
  40. Lewy body dementia is the second most common dementia, on a spectrum with Parkinson's Louis Nervegna · May 07, 2026 · Facebook
  41. Boston Heart's desmosterol test is likely a waste of money, argues Louis Louis Nervegna · Jan 15, 2024 · Facebook
  42. Keeping blood pressure below 130/80 linked to 15% lower dementia risk in a Chinese study Louis Nervegna · Dec 20, 2025 · Facebook
  43. ARBs, thiazides and DHP calcium blockers tied to fewer dementia markers than ACE drugs Louis Nervegna · Feb 18, 2026 · Facebook
  44. Metformin associated with over 50% lower dementia risk in 20-year DPP/DPPOS follow-up Louis Nervegna · Aug 25, 2026 · Facebook
  45. Shingles vaccine tied to 46% fewer major cardiac events in high-risk people Louis Nervegna · Mar 26, 2026 · Facebook
  46. High-dose flu vaccine linked to lower Alzheimer's risk than standard dose Louis Nervegna · Apr 02, 2026 · Facebook
  47. VITACOG: B vitamins cut brain atrophy 30% in mild cognitive impairment Louis Nervegna · Jun 20, 2026 · Facebook
  48. Tufts: B vitamins can help older people with high homocysteine protect brain and heart Louis Nervegna · Sep 08, 2025 · Facebook
  49. Even 'normal' vitamin B12 may be too low for older brains; active B12 tied to lesions Louis Nervegna · May 23, 2026 · Facebook
  50. Low blood vitamin C linked to brain changes, likely a proxy for fruit and vegetables Louis Nervegna · Jul 05, 2026 · Facebook
  51. Creatine 20 g/day improved cognition in Alzheimer's patients by nearly 5% in 8 weeks Louis Nervegna · Sep 22, 2025 · Facebook
  52. Four-supplement cocktail improved cognition 29% vs 14% in a phase II Alzheimer's trial Louis Nervegna · Jan 03, 2026 · Facebook
  53. Harvard study ties lithium deficiency to Alzheimer's disease in mice and humans Louis Nervegna · Aug 15, 2025 · Facebook
  54. Human trials of lithium orotate for Alzheimer's to start spring 2026 at MGH/Brigham Louis Nervegna · Jan 28, 2026 · Facebook
  55. Correction: low-dose lithium inhibits overactive mTOR in the brain Louis Nervegna · Nov 11, 2025 · Facebook
  56. Case report: major Alzheimer's symptom improvement after fecal microbiota transplantation Louis Nervegna · Jan 02, 2026 · Facebook
  57. Plasma p-tau217 predicts dementia: 3x per SD, 7x top vs bottom quartile in 2,766 women Louis Nervegna · Apr 05, 2026 · Facebook
  58. Finger-prick blood test for Alzheimer's pathology may be coming Louis Nervegna · Jan 12, 2026 · Facebook
  59. Framingham: lower small dense LDL linked to lower Alzheimer's risk Louis Nervegna · May 31, 2025 · Facebook

Keep exploring

Related research summaries

Topics and hashtags in this summary